Foghorn Therapeutics Appoints Ryan Maynard CFO-March 2024-www.financetom.com

Foghorn Therapeutics Appoints Ryan Maynard CFO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Foghorn Therapeutics Appoints Ryan Maynard CFO

Mar 11, 2026 5:04 AM

07:43 AM EST, 02/23/2026 (MT Newswires) -- Foghorn Therapeutics ( FHTX ) said Monday that Ryan Maynard will join the clinical-stage biotechnology company as chief financial officer effective Feb. 23.

Maynard brings more than 25 years of biotech finance experience and was most recently CFO at Cara Therapeutics, where he led financial strategy and strategic transactions.

Maynard previously held CFO roles at Rigel Pharmaceuticals, LetsGetChecked, and Blade Therapeutics, and has raised over $1 billion in financing. He also serves on the board of Iovance Biotherapeutics.

Previous page： Zevra Therapeutics Q4 Net Loss Widens, Revenue Decreases; Shares Fall After Hours Next page： Nuscale Power Insider Sold Shares Worth $494,487, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Zevra Therapeutics Q4 Net Loss Widens, Revenue Decreases; Shares Fall After Hours

Mar 11, 2025

04:58 PM EDT, 03/11/2025 (MT Newswires) -- Zevra Therapeutics ( ZVRA ) reported a Q4 net loss Tuesday of $0.67 per diluted share, wider than a loss of $0.51 a year earlier. Analysts polled by FactSet expected a loss of $0.38. Net revenue for the quarter ended Dec. 31 was $12 million, down from $13.2 million a year earlier. Analysts...

Nuscale Power Insider Sold Shares Worth $494,487, According to a Recent SEC Filing

Mar 11, 2025

04:58 PM EDT, 03/11/2025 (MT Newswires) -- Robert Ramsey Hamady, Chief Financial Officer, on March 07, 2025, sold 31,496 shares in Nuscale Power ( SMR ) for $494,487. Following the Form 4 filing with the SEC, Hamady has control over a total of 29,985 Class A common shares of the company, with 29,985 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1822966/000182296625000046/xslF345X05/wk-form4_1741726093.xml ...

Addus HomeCare COO Bradley Bickham to Retire in 2026

Mar 11, 2025

04:57 PM EDT, 03/11/2025 (MT Newswires) -- Addus HomeCare ( ADUS ) said Tuesday that W. Bradley Bickham, its president and chief operating officer, will retire in March 2026. Additionally, the board extended its chairman and chief executive officer Dirk Allison's term at the company by an additional three years through March 2028, the provider of home care services said...

Curtiss-Wright Wins $50 Million Navy Contract for Data Acquisition Systems

Mar 11, 2025

04:59 PM EDT, 03/11/2025 (MT Newswires) -- Curtiss-Wright ( CW ) said Tuesday it won a nearly $50 million firm-fixed-price indefinite delivery, indefinite quantity contract from Naval Air Systems Command for high-speed data acquisition systems hardware and repair services for the Special Flight Test Instrumentation Pool. The contract, running through January 2030, includes Curtiss-Wright's ( CW ) full flight test...